606
Views
4
CrossRef citations to date
0
Altmetric
Research Article

The convenient synthesis and evaluation of the anticancer activities of new resveratrol derivatives

, , , , , & show all
Pages 328-336 | Received 27 Jan 2008, Accepted 12 Mar 2008, Published online: 20 Oct 2008
 

Abstract

In the present study we report the simple synthesis and antitumour activity of novel stilbene derivatives 1322. The key synthetic strategies involved Wadsworth-Horner-Emmons condensation and coupling reactions in high yields. All compounds showed significant growth inhibition on human tumour cell lines, with the most potent compound (19) exhibiting an IC50 of 5.7 μM – 11.4 μM in vitro.

Acknowledgements

This work has been supported by a KOSEF Brain Neurobiology Grant (2007), Ewha Global Challenge (BK21) grant, a research grant from the Ministry of Health & Welfare (Project No B040002), the Republic of Korea, E. L and Y. L the fellowship of the BK 21 program from the Ministry of Education and Human Resources Development and the Seoul Science Fellowship Program, and a grant (20070301-034-026-007-04-00) from BioGreen 21 Program, Rural Development Administration, Republic of Korea. Hyung-In Moon and Ill-Min Chung equally contributed to this work.

Declaration of interest: The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.